Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| MINT DIAGNOSTICS | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
In donors or patients undergoing assisted reproduction treatments (ART) it is necessary to closely control ovarian stimulation to monitor the number and size of developing follicles.
Oestradiol (E2) and progesterone (P4) are products of steroidogenesis. Their concentrations increase with the diameter of the growing follicle. In order to assess treatment response and support clinical decisions, accurate and reliable methods to measure E2 and P4 are essential. Measurement of both hormones, as well as monitoring of follicle growth through ultrasound measurements, is an important part of ovarian stimulation, requiring patients or donors to undergo multiple blood draws. It is often a physically and emotionally painful process, and the most convenient solution is the measurement of hormones concentrations in other biological fluids, such as saliva. Salivary diagnostic tests are a less invasive, inexpensive, and stress-free alternative.
The current study pretends to evaluate the correlation between salivary ELISA assays and serum determination of progesterone and oestradiol concentrations in oocyte donors, and, also, evaluate the feasibility of doing saliva E2 and P4 determinations in the IVIRMA clinic labs.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| DONORS UNDER CONTROLLED OVARIAN STIMULATION | Experimental | Saliva samples will be analyzed using oestradiol and progesterone ELISA kits. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Determination of progesterone and oestradiol | Diagnostic Test | Blood and saliva samples will be taken for determination of progesterone and oestradiol hormones. |
|
| Measure | Description | Time Frame |
|---|---|---|
| E2 and P4 on Day 1 | Measurement of saliva E2 adn P4 values on day 1 stimulation | 1 YEAR |
| E2 and P4 on Day 8 | Measurement of saliva E2 adn P4 values on day 8 of stimulation | 1 YEAR |
| E2 and P4 on Triggering day | Measurement of saliva E2 adn P4 values on triggering day | 1 YEAR |
| Measure | Description | Time Frame |
|---|---|---|
| BODY MASS INDEX | Measurement of body mass index | 1 year |
| DONOR'S AGE | Age at the procedure moment | 1 year |
Not provided
Inclusion criteria
Exclusion criteria
• Simultaneous participation in other clinical study, that at the investigator's criteria could interfere with the results of this study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ivi Madrid | Recruiting | Madrid | 28023 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007247 | Infertility, Female |
| D007246 | Infertility |
| ID | Term |
|---|---|
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
This is a prospective multicentric study,
Not provided
Not provided
Not provided
Not provided
| NUMBER OF OOCYTES | Number of oocytes collected | 1 YEAR |
| IVI Valencia | Recruiting | Valencia | 46015 | Spain |
|
| D000091662 | Genital Diseases |